Investor Relations

RSS Content

Vanda Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 7, 2018
Conference Call and Webcast to Follow

WASHINGTON, Oct. 22, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter of 2018 on Wednesday, November 7, 2018, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, November 7, 2018, during which management will discuss the third quarter 2018 financial results and other corporate activities. To participate in the conference call, please dial 1-888-771-4371 (domestic) or 1-847-585-4405 (international) and use passcode 47697858.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, November 7, 2018, beginning at 7:00 PM ET and will be accessible until Wednesday, November 14, 2018, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 47697858.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

Cision View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2018-financial-results-on-november-7-2018-300735520.html

SOURCE Vanda Pharmaceuticals Inc.

  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy